
Endocrine Society statement highlights key research gaps on obesity drugs—who benefits, long-term dosing, safety, and measuring success beyond weight loss.
VIDEO: Patients with obesity are at increased risk for the SARS-CoV-2 infection and for more dangerous complications, explains obesity researcher Donna Ryan, MD.
Patients with obesity are at increased risk for the SARS-CoV-2 infection and for more dangerous complications, explains obesity researcher Donna Ryan, MD.
Dr Ryan is Professor Emerita, Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, Louisiana, current president of the World Obesity Federation and the primary author of a recent


